Hamilton Wealth’s AbbVie ABBV Stock Holding History

Hamilton Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.85M	Buy	22,320 +96	+0.4%	+$21.3K	0.95%	29
2025 Q4	$5.08M	Buy	22,224 +995	+5%	+$227K	0.97%	27
2025 Q3	$4.92M	Buy	+21,229	New	+$4.32M	1.03%	27
2025 Q2	–	Sell	-1,160	Closed	-$243K	–	105
2025 Q1	$243K	Buy	+1,160	New	+$226K	0.06%	88
2020 Q3	–	Sell	-21,349	Closed	-$2.1M	–	52
2020 Q2	$2.1M	Sell	21,349 -18,036	-46%	-$1.59M	1.25%	26
2020 Q1	$3M	Buy	+39,385	New	+$3.35M	2.24%	23

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hamilton Wealth's ABBV Position: Q1 2026 in Review

Hamilton Wealth increased its AbbVie (ABBV) stake by 0.43% in Q1 2026, buying an estimated $21.3K and bringing the position to 22,320 shares worth $4.85M. The position accounts for 0.95% of the portfolio, ranked #29.

Hamilton Wealth first reported a position in ABBV in Q1 2020 and has held it in 6 quarters since. The position peaked at $5.08M in Q4 2025. 4,081 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Hamilton Wealth held 22,320 shares of AbbVie worth $4.85M as of Q1 2026.
Hamilton Wealth bought 96 AbbVie shares in Q1 2026, an estimated $21.3K.
AbbVie made up 0.95% of Hamilton Wealth's portfolio in Q1 2026, its #29 holding.
Hamilton Wealth first reported a position in AbbVie in Q1 2020 and has held it in 6 quarters since.
Hamilton Wealth's AbbVie position peaked at $5.08M in Q4 2025.
4,081 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Hamilton Wealth's 13F filing for Q1 2026, filed 18 May 2026.